Saturday, September 23, 2023
Saturday, September 23, 2023

Omaha Children’s Hospital and Medical Center’s New Expansion Supports Kids & Their Families with Oneview’s Latest Patient Engagement Software

Children’s Hospital and Medical Center in Omaha, NE have successfully gone live with Oneview’s CXP Enterprise solution.

Children’s has been leading the region in pediatric care since its opening and recently opened their Hubbard Center for Children. The Hubbard Center doubles the health system’s capacity featuring enhanced surgical space and expanding the hospital’s radiology and emergency departments. It also houses the hospital’s neonatal and pediatric ICUs, the fetal care center, a cardiac care unit, and a hematology and oncology unit.

The new hospital is equipped with the latest technology, including Oneview-powered Samsung displays and Samsung tablets in patient rooms. The Oneview system will help children and their families become more comfortable and knowledgeable during their stay at the Children’s facility. The new system ensures all patients have personalized access to information regarding their stay by providing information on dining, care teams, parking, entertainment, and other hospital amenities.

Oneview’s CXP Enterprise solution will also help the staff at Children’s by enabling care teams to engage patients, reducing non-clinical demands, and optimize clinical and operational effectiveness including delivery of telehealth programs such as virtual therapy and language services.

“The Hubbard Center for Children offers our team the space, equipment, and innovation they need to continue to be excellent and deliver the best outcomes and experiences for patients and families,” says Chanda Chacón, Children’s President & CEO. “With its opening, more children will have access to the care they need, closer to home, for generations to come. This is a historic milestone on our journey to fulfill our mission: to improve the life of every child.”

“Implementing the Oneview solution aligns with our mission to provide children and families comfort and education when they need it most. Our goal is to provide the best care and an exceptional experience for our patients by providing a wide range of options for entertainment, education, virtual care and translation services, and a plethora of other convenient services at the bedside,” says Jerry Vuchak, Children’s CIO. “This is just the beginning, and we will continue to work with Oneview to enhance our use of the platform with additional functionality to best serve our patients and family members into the future.”

“The team at Children’s, together with the community, had a clear vision for the future of pediatric care in Omaha. We at Oneview are honored to have been part of this journey, and to have collaborated on a smooth implementation” commented Niall O’Neill, Chief Customer Officer at Oneview. “We look forward to a long and innovative partnership, helping power exemplary care experiences for the kids, families, and care givers of Children’s.”

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

FDA OK’s ensoETM for Use in Cardiac Ablations to Reduce Risk of Esophageal Injury

Published studies that have examined the use of ensoETM for this purpose include the pilot eCOOL-AF study, the IMPACT study and a large multi-center analysis of over 25,000 patients (in press at the Journal of the American College of Cardiology: Clinical Electrophysiology). These studies have found up to an 83 percent reduction in esophageal injuries, and a significant reduction in risk of atrioesophageal fistula (AEF), one of the most dreaded complications of ablation procedures. Receives FDA Clearance and Breakthrough Device Designation has also received FDA Breakthrough Device Designation for its obstructive hydrocephalus software tool. This is the first radiology triage device to be granted Breakthrough status since the inception of the FDA Breakthrough Devices Program.

By using this website you agree to accept Medical Device News Magazine Privacy Policy